Jörgen Persson

Dunross & Co. AB (D&C) is a private placement firm located in Gothenburg, Sweden. D&C was established in 1989 as an independent firm owned and managed by their CEO and founder, Sven Norfeldt.

Cellectricon AB provides cell-based screening services to accelerate drug discovery. The firm develops and validates exciting central nervous system and peripheral pain assays using primary cells, accelerating the path from assay validation to compound screening. Its system is equipped with an imaging-based microplate reader to simultaneously record transient fluorescence and luminescence signals, providing real-time monitoring and readouts of cell culture response. The company was founded by Jan Owe Owesson Orwar, Daniel T. Chiu and Stig Anders Jakob Lindberg in 1999 and is headquartered in Molndal, Sweden.